These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10795729)

  • 1. Postmenopausal hormone replacement therapy and cardiovascular mortality in Central-Eastern Europe.
    Acs N; Vajo Z; Miklos Z; Siklósi G; Paulin F; Szekacs B
    J Gerontol A Biol Sci Med Sci; 2000 Mar; 55(3):M160-2. PubMed ID: 10795729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hormone replacement therapy by postmenopausal women in the United States.
    Keating NL; Cleary PD; Rossi AS; Zaslavsky AM; Ayanian JZ
    Ann Intern Med; 1999 Apr; 130(7):545-53. PubMed ID: 10189323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription of hormone replacement therapy in postmenopausal women with renal failure.
    Stehman-Breen CO; Gillen D; Gipson D
    Kidney Int; 1999 Dec; 56(6):2243-7. PubMed ID: 10594801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormone use in women with acute coronary syndromes.
    Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
    J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychological aspects of decision-making by women about using hormone replacement therapy].
    Olejek A
    Wiad Lek; 2000; 53(1-2):92-7. PubMed ID: 10806928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy for African American women: missed opportunities for effective intervention.
    Nicholson WK; Brown AF; Gathe J; Grumbach K; Washington AE; Pérez-Stable EJ
    Menopause; 1999; 6(2):147-55. PubMed ID: 10374222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000.
    Kesteloot H; Sans S; Kromhout D
    Eur Heart J; 2006 Jan; 27(1):107-13. PubMed ID: 16204263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy, renal function and heart ultrasonographic parameters in postmenopausal women: an observational study.
    Vitolo E; Comassi M; Caputo MT; Solini A
    Int J Clin Pract; 2015 Jun; 69(6):632-7. PubMed ID: 25496443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.
    Tackett AH; Bailey AL; Foody JM; Miller JM; Apperson-Hansen C; Ohman EM; Hochman JS; Karnash SL; Califf RM; Topol EJ; Moliterno DJ
    Am Heart J; 2010 Oct; 160(4):678-84. PubMed ID: 20934562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women.
    Gabriel SR; Carmona L; Roque M; Sánchez GL; Bonfill X
    Cochrane Database Syst Rev; 2005 Apr; (2):CD002229. PubMed ID: 15846631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997.
    MacLennan AH; Wilson DH; Taylor AW
    Med J Aust; 1999 Jun; 170(11):524-7. PubMed ID: 10397042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy.
    Armstrong K; Popik S; Guerra C; Ubel PA
    Med Decis Making; 2000; 20(3):308-13. PubMed ID: 10929853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
    Chin BS; Futaba K; Jethwa A; Lip GY
    Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V; Banks E; Reeves G
    Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular health in the menopausal woman: impact of the timing of hormone replacement therapy.
    Rosano G; Vitale C; Spoletini I; Fini M
    Climacteric; 2012 Aug; 15(4):299-305. PubMed ID: 22424090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project.
    Lundberg V; Tolonen H; Stegmayr B; Kuulasmaa K; Asplund K;
    Maturitas; 2004 May; 48(1):39-49. PubMed ID: 15223107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine in postmenopausal women and the importance of hormone replacement therapy.
    Mijatovic V; van der Mooren MJ
    Clin Chem Lab Med; 2001 Aug; 39(8):764-7. PubMed ID: 11592448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy--is there a place for its use in neurology?
    Vuković V; Lovrencić-Huzjan A; Solter VV; Dordević V; Demarin V
    Coll Antropol; 2003 Jun; 27(1):413-24. PubMed ID: 12974172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Initiating Hormone Replacement Therapy in Postmenopausal Women: A Cross-Sectional Study.
    Çilgin H
    ScientificWorldJournal; 2019; 2019():1814804. PubMed ID: 30728754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.